• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A review of controlled studies with nomifensine, performed outside the UK.对诺米芬辛进行的对照研究综述,该研究在英国境外开展。
Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):237S-241S. doi: 10.1111/j.1365-2125.1977.tb05759.x.
2
[Nomifensine: clinical data (author's transl)].[诺米芬辛:临床数据(作者译)]
Nouv Presse Med. 1978 Jun 28;7(26):2295-304.
3
Controlled randomized group comparison of nomifensine and imipramine in depressive illness.诺米芬辛与丙咪嗪治疗抑郁症的对照随机分组比较
Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):215S-220S. doi: 10.1111/j.1365-2125.1977.tb05755.x.
4
Dopaminergic agonist nomifensine compared with amitriptyline: a double-blind clinical trial in acute primary depressions.多巴胺能激动剂诺米芬辛与阿米替林的比较:急性原发性抑郁症的双盲临床试验
Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):221S-225S. doi: 10.1111/j.1365-2125.1977.tb05756.x.
5
Contrasts in antidepressant medications.抗抑郁药物的对比。
Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):153S-156S. doi: 10.1111/j.1365-2125.1977.tb05743.x.
6
A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.诺米芬辛、丙咪嗪和安慰剂对老年门诊抑郁症患者疗效及安全性的双盲对比评估
J Clin Psychiatry. 1984 Apr;45(4 Pt 2):73-7.
7
A double-blind evaluation of nomifensine and imipramine in depressed outpatients.对门诊抑郁症患者进行的诺米芬辛与丙咪嗪双盲评估。
Am J Psychiatry. 1979 Jun;136(6):841-3. doi: 10.1176/ajp.136.6.841.
8
A double-blind comparison of nomifensine and amitriptyline in the treatment of depression.诺米芬辛与阿米替林治疗抑郁症的双盲比较。
Acta Psychiatr Scand. 1981 Mar;63(3):198-207. doi: 10.1111/j.1600-0447.1981.tb00668.x.
9
A double-blind clinical comparison between nomifensine and amitriptyline in the treatment of endogenous depressions.诺米芬辛与阿米替林治疗内源性抑郁症的双盲临床对照研究。
Int Pharmacopsychiatry. 1982;17 Suppl 1:97-105. doi: 10.1159/000468604.
10
Nomifensine and amitriptyline in the treatment of depression. A multi-centre double-blind comparison.诺米芬辛与阿米替林治疗抑郁症的多中心双盲比较。
Acta Psychiatr Scand. 1983 Sep;68(3):212-20. doi: 10.1111/j.1600-0447.1983.tb07000.x.

引用本文的文献

1
The politics and bio-ethics of regulatory trust: case-studies of pharmaceuticals.监管信任的政治与生物伦理:药物案例研究
Med Health Care Philos. 2008 Dec;11(4):415-26. doi: 10.1007/s11019-008-9155-x. Epub 2008 Jul 22.
2
Unwanted symptoms in depressed patients treated with viloxazine: an algorithm for identification of illness-related symptoms.接受维洛沙嗪治疗的抑郁症患者的不良症状:一种识别疾病相关症状的算法
Eur J Clin Pharmacol. 1983;24(2):277-81. doi: 10.1007/BF00613832.
3
Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.诺米芬辛:其药理特性及对抑郁症治疗效果的综述
Drugs. 1979 Jul;18(1):1-24. doi: 10.2165/00003495-197918010-00001.

本文引用的文献

1
[Results of an open and a double-blind study of nomifensin in comparison to imipramin (author's transl)].与丙咪嗪相比,诺米芬辛的开放和双盲研究结果(作者译)
Arch Psychiatr Nervenkr (1970). 1974;219(3):265-76. doi: 10.1007/BF00342052.
2
A double blind comparative trial of nomifensin and desimipramine in depression. Relationship between treatment and phenylethylamine excretion.诺米芬辛与地昔帕明治疗抑郁症的双盲对照试验。治疗与苯乙胺排泄之间的关系。
Eur J Clin Pharmacol. 1976 Jun 15;10(2):109-13. doi: 10.1007/BF00609468.
3
Some of the problems and difficulties associated with clinical studies of antidepressant agents.与抗抑郁药临床研究相关的一些问题和困难。
Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):199S-207S. doi: 10.1111/j.1365-2125.1977.tb05753.x.
4
Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly.
J Clin Pharmacol. 1977 Jan;17(1):81-3. doi: 10.1002/j.1552-4604.1977.tb04589.x.

对诺米芬辛进行的对照研究综述,该研究在英国境外开展。

A review of controlled studies with nomifensine, performed outside the UK.

作者信息

Habermann W

出版信息

Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):237S-241S. doi: 10.1111/j.1365-2125.1977.tb05759.x.

DOI:10.1111/j.1365-2125.1977.tb05759.x
PMID:334230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1429098/
Abstract
  1. Double-blind controlled comparisons of nomifensine with placebo, imipramine, desipramine, viloxazine, nortriptyline, a combination of amitriptyline and chlordiazepoxide, and diazepam have been carried out in various parts of the world. 2. Dosage ranged from 50-225 mg daily, and treatment lasted from 2-26 weeks. 3. Nomifensine was shown to possess useful antidepressive activity, to counteract inhibition, to restore drive and to relieve anxiety. 4. Adverse reactions were uncommon, particularly anticholinergic effects, and nomifensine was not shown to cause sedation or to interact with alcohol. No withdrawal phenomena were observed after 6 months' treatment. 5. Nomifensine is not suitable for severely agitated patients.
摘要
  1. 世界上不同地区已对诺米芬辛与安慰剂、丙咪嗪、地昔帕明、维洛沙嗪、去甲替林、阿米替林与氯氮卓的复方制剂以及地西泮进行了双盲对照比较。2. 剂量范围为每日50 - 225毫克,治疗持续2 - 26周。3. 诺米芬辛显示具有有效的抗抑郁活性,可对抗抑制作用,恢复动力并缓解焦虑。4. 不良反应不常见,尤其是抗胆碱能作用,且未显示诺米芬辛会引起镇静作用或与酒精相互作用。治疗6个月后未观察到戒断现象。5. 诺米芬辛不适用于严重躁动的患者。